May 23, 2018 4:36 AM ET

Pharmaceuticals

Company Overview of Nabriva Therapeutics AG

Audit Committee of Nabriva Therapeutics AG

Name (Connections)Board RelationshipsTitleKey Developments
Daniel Burgess 91 RelationshipsChairman of the Supervisory Board
Charles Rowland Jr., CPA, MBA45 RelationshipsMember of the Supervisory Board
Stephen Webster 50 RelationshipsMember of Supervisory Board

Compensation Committee*

Name (Connections)Board RelationshipsTitle
Axel Bolte 36 RelationshipsDeputy Chairman of the Supervisory Board
Chau Khuong 70 RelationshipsMember of the Supervisory Board
Charles Rowland Jr., CPA, MBA45 RelationshipsMember of the Supervisory Board
Nabriva Therapeutics AG Compensation vs. Industry
431.8K
377.4K
Chief Executive Officer
Nabriva Therapeutics AG
Industry Average

Nominating Committee*

Name (Connections)Board RelationshipsTitleKey Developments
Daniel Burgess 91 RelationshipsChairman of the Supervisory BoardNo relevant key developments are available at this time.
Stephen Webster 50 RelationshipsMember of Supervisory Board

Corporate Governance Committee*

Name (Connections)Board RelationshipsTitle
Daniel Burgess 91 RelationshipsDeputy Chairman of the Supervisory Board
Stephen Webster 50 RelationshipsMember of the Supervisory Board
and Competitor
Insiders vs. External
Board
Nabriva Therapeutics AG
0%
100%
There is no Key Competitor Insiders data available

Supervisory Committee*

Name (Board Relationships)/Title Board Affiliations
Axel Bolte 36 Relationships
Deputy Chairman of the Supervisory Board
No other board affiliations
Daniel Burgess 91 Relationships
Chairman of the Supervisory Board
No other board affiliations
Chau Khuong 70 Relationships
Member of the Supervisory Board
No other board affiliations
Charles Rowland Jr., CPA, MBA45 Relationships
Member of the Supervisory Board
No other board affiliations
George Talbot M.D.58 Relationships
Member of the Supervisory Board
No other board affiliations
Stephen Webster 50 Relationships
Member of Supervisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Active Committee Members by Competitor

SymbolCommittee MemberNumber of Committees
There is no Active Committee Members data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Nabriva Therapeutics AG, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.